Showing 15,461 - 15,480 results of 32,069 for search '(( 50 ((((a decrease) OR (mean decrease))) OR (nn decrease)) ) OR ( e point decrease ))', query time: 0.66s Refine Results
  1. 15461

    Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents by Anastasia Hyrina (3860455)

    Published 2017
    “…Pre-treatment of Huh-7.5.1 cells with PF-429242 results in a dose-dependent inhibition of DENV infection [median inhibitory dose (EC<sub>50</sub>) = 1.2 microM; median cytotoxic dose (CC<sub>50</sub>) = 81 microM; selectivity index (SI) = 68)] and a ~3-log decrease in DENV-2 titer with 20 microM of PF-429242. …”
  2. 15462

    DataSheet_1_Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.docx by Li Tao (154250)

    Published 2021
    “…</p>Results<p>Six RCTs involving 4,227 patients were identified after a systematic search. For OS, ICI and anti-VEGF combination therapy decreased mortality approximately 30% in the intention-to-treat population (ITT) (hazard ratio (HR) = 0.70, 95% CI: 0.57–0.87), but there was no statistical difference in patients evaluated as “favorable” by the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) criteria compared with monotherapy (HR = 0.90, 95% CI: 0.55–1.46, p = 0.66). …”
  3. 15463
  4. 15464
  5. 15465
  6. 15466
  7. 15467
  8. 15468

    DataSheet_1_Efficacy of nucleos(t)ide analogues(NAs) in preventing virus reactivation in oncology patients with HBV infection after chemotherapy or surgery: A network meta-analysis... by Yuqing Zhao (50691)

    Published 2023
    “…Objective<p>In this study, we aimed to perform a network meta-analysis to compare the effectiveness of NAs in decreasing the reactivation of HBV, reducing chemotherapy disruption, and improving survival in oncology patients.…”
  9. 15469

    Table1_Relationship between serum uric acid levels and uric acid lowering therapy with the prognosis of patients with heart failure with preserved ejection fraction: a meta-analysi... by Linzhi Li (697796)

    Published 2024
    “…However, it was associated with a decreased risk of hospitalization due to HF (RR: 0.85, 95% CI: 0.79–0.91, P < 0.001).…”
  10. 15470
  11. 15471
  12. 15472

    Data_Sheet_1_The effect of omega-3 fatty acids and its combination with statins on lipid profile in patients with hypertriglyceridemia: A systematic review and meta-analysis of ran... by Yunjiao Yang (4966963)

    Published 2022
    “…Background/Aim<p>Omega-3 fatty acids (OM3-FA), a promising treatment for high triglycerides, have gradually attracted public attention. …”
  13. 15473

    Supplementary materials: Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis... by Simon Shohet (17882674)

    Published 2024
    “…<b>Results:</b> Network B (full evidence analysis) showed that cipa+mig was associated with a relative increase in 6MWD (mean difference 28.93 m, 95% credible interval [8.26–50.11 m]; Bayesian probability 99.7%) and FVC (2.88 pp [1.07–4.71 pp]; >99.9%) compared with aval. …”
  14. 15474

    DataSheet_1_Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma.pdf by Paul D. Bates (7178726)

    Published 2021
    “…<p>Management for high-risk neuroblastoma (NBL) has included autologous hematopoietic stem cell transplant (HSCT) and anti-GD2 immunotherapy, but survival remains around 50%. The aim of this study was to determine if allogeneic HSCT could serve as a platform for inducing a graft-versus-tumor (GVT) effect against NBL with combination immunocytokine and NK cells in a murine model. …”
  15. 15475

    DataSheet_1_Dynamic Change of Thyroid Hormones With Postmenstrual Age in Very Preterm Infants Born With Gestational Age <32 Weeks: A Multicenter Prospective Cohort Study.pdf by Ranran Shi (10498970)

    Published 2021
    “…The results prompt that age-related cutoffs, instead of a single reference range, might be more useful to explain the thyroid function of VPIs. …”
  16. 15476

    DataSheet_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.doc by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”
  17. 15477

    Table_5_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”
  18. 15478

    Table_7_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”
  19. 15479

    Table_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”
  20. 15480

    Table_2_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…Anti-spike IgG, IgM, and IgA levels decreased at t3, with IgG levels further waning at t4 and resulting in >30% seronegativity. …”